Deciphering the tumour immune microenvironment cell by cell

Immune checkpoint inhibitors (ICIs) have rejuvenated therapeutic approaches in oncology. Although responses tend to be durable, response rates vary in many cancer types. Thus, the identification and validation of predictive biomarkers is a key clinical priority, the answer to which is likely to lie...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabhan, M., Egan, D., Kreileder, M., Zhernovkov, V., Timosenko, E., Slidel, T., Dovedi, S., Glennon, K., Brennan, D., Kolch, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206805/
https://www.ncbi.nlm.nih.gov/pubmed/37234284
http://dx.doi.org/10.1016/j.iotech.2023.100383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206805/
https://www.ncbi.nlm.nih.gov/pubmed/37234284
http://dx.doi.org/10.1016/j.iotech.2023.100383

Ejemplares similares